Regeneron Pharmaceuticals
REGN
$569.82
Share price
-0.14%
Change (1 day)
-47.34%
Change (1 year)
Categories
Market capitalization of Regeneron Pharmaceuticals (REGN)
Market cap: $61.52 Billion USD
As of July 2025 Regeneron Pharmaceuticals has a market cap of $61.52 Billion USD. This makes Regeneron Pharmaceuticals the world's 346th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Regeneron Pharmaceuticals from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | $61.52 B | -21.42% |
| 2024 | $78.28 B | -18.19% |
| 2023 | $95.68 B | 21.78% |
| 2022 | $78.57 B | 15.69% |
| 2021 | $67.91 B | 31.74% |
| 2020 | $51.55 B | 24.5% |
| 2019 | $41.40 B | 1.7% |
| 2018 | $40.71 B | 0.79% |
| 2017 | $40.39 B | 4.33% |
| 2016 | $38.71 B | -31.85% |
| 2015 | $56.81 B | 35.19% |
| 2014 | $42.02 B | 53.15% |
| 2013 | $27.43 B | 64.85% |
| 2012 | $16.64 B | 224.35% |
| 2011 | $5.13 B | 74.8% |
| 2010 | $2.93 B | 49.69% |
| 2009 | $1.96 B | 34.11% |
| 2008 | $1.46 B | -23.21% |
| 2007 | $1.90 B | 45.08% |
| 2006 | $1.31 B | 46.27% |
| 2005 | $0.89 B | 74.43% |
| 2004 | $0.51 B | -37.05% |
| 2003 | $0.81 B | -0.78% |
| 2002 | $0.82 B | -33.46% |
| 2001 | $1.23 B | -4.59% |
| 2000 | $1.29 B | 223.87% |
| 1999 | $0.40 B | 75.14% |
| 1998 | $0.22 B | -13.61% |
| 1997 | $0.26 B | -36.05% |
| 1996 | $0.41 B |
End of Day market cap according to different sources
On Jul 14th, 2025 the market cap of Regeneron Pharmaceuticals was reported to be:
$61.60 Billion USD
$61.60 Billion USD
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $159.47 B | 159.22% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $41.12 B | -33.15% | 🇺🇸 USA |
 Biogen BIIB | $19.41 B | -68.45% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $377.65 B | 513.88% | 🇺🇸 USA |
 Novartis NVS | $239.70 B | 289.64% | 🇨🇭 Switzerland |
 Sanofi SNY | $118.24 B | 92.20% | 🇫🇷 France |